为什么透析中低血压是门诊透析治疗最常见的并发症?
透析中低血压(IDH)是血液透析(HD)治疗中最常见的并发症,慢性肾脏病门诊透析患者的发生频率为10%至12%,与心脑等重要器官的暂时性缺血应激及患者死亡率增加相关。尽管多年来IDH有多种定义,但绝对最低收缩压(SBP)与患者结局的关联最强。统一的病理生理机制是有效血容量减少导致血浆张力降低,若神经体液系统激活不能充分代偿,则小动脉张力和血压下降。
要点
- IDH是门诊血液透析患者最常见的并发症,发生频率为10%至12%。
- 绝对最低收缩压与患者结局的关联最强。
- 有效血容量减少导致血浆张力降低是IDH的统一病理生理机制。
核心结论
- IDH是血液透析治疗中最常见的并发症,慢性肾脏病门诊透析患者的发生频率为10%至12%,与心脑等重要器官的暂时性缺血应激及患者死亡率增加相关。
研究设计与样本
- 本文为综述,检索范围未报告。
主要发现
- IDH在慢性肾脏病门诊透析患者中的发生频率为10%至12%。
- 绝对最低收缩压与患者结局的关联最强。
- 有效血容量减少导致血浆张力降低,若神经体液系统激活不能充分代偿,则小动脉张力和血压下降。
- IDH的危险因素众多,包括患者相关因素(年龄、合并症伴心脏储备降低)、患者对饮食和生活方式建议的依从性、与体外循环和药物的反应、透析液成分和温度的选择、透析后目标体重的设定、超滤率和 profiling。
- 透析机技术的进步通过提供有效循环血容量的实时估计和调整透析液成分以维持血管张力正在开发中,但目前需要更复杂的生物反馈回路才能在临床有效预防IDH。
关键数值与推荐
- IDH的定义:多年来有多种定义,绝对最低收缩压与患者结局的关联最强。
临床怎么用
- 在等待人工智能进步的同时,临床医生继续依赖患者教育来限制透析间期体重增长、频繁评估透析后目标体重、调整透析液成分和温度、引入对流疗法以增加热损失,以及改变透析时长和频率以降低超滤率需求。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intradialytic hypotension (IDH) is the most frequent complication of hemodialysis (HD) treatments with a frequency of 10% to 12% for patients with chronic kidney disease attending for outpatient treatments and is associated with both temporary ischemic stress to vital organs, including the heart and brain, and increased patient mortality. Although there have been many different definitions of IDH over the years, an absolute nadir systolic blood pressure (SBP) has the strongest association with patient outcomes. The unifying pathophysiology is one of reduced effective blood volume, resulting in lower plasma tonicity, and if this cannot be adequately compensated for by activation of neurohumeral systems, then arteriolar tone and blood pressure fall. The risk factors for developing IDH are numerous, ranging from patient-related factors, including age and comorbidity with reduced cardiac reserve, to patient compliance with dietary and lifestyle advice, to reactions with the extracorporeal circuit and medications, choice of dialysate composition and temperature, setting of postdialysis target weight, ultrafiltration rate, and profiling. Advances in dialysis machine technology by providing real time estimates of the effective circulating volume and adjusting dialysate composition to maintain vascular tonicity are being developed, but currently require more sophisticated biofeedback loops to be clinically effective in preventing IDH. While awaiting advances in artificial intelligence, the clinician continues to rely on patient education to limit interdialytic weight gains, frequent assessment of the postdialysis target weight, adjusting dialysate composition and temperature, introducing convective therapies to increase thermal losses, and altering dialysis session duration and frequency to reduce ultrafiltration rate requirements.
引用
- Davenport A. Why is Intradialytic Hypotension the Commonest Complication of Outpatient Dialysis Treatments? Kidney Int Rep. 2022. PMID: 36938081. doi:10.1016/j.ekir.2022.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。